To our customers
Dear Valued Customer,
For more than 40 years, Sorin Group’s Heart Valve Business Unit has led the field with cutting-edge research and development, high quality manufacturing and distribution, and outstanding services and support—all focused on delivering the best solutions in cardiac care.
Our innovations and industry “firsts” have had a profound effect on medicine. From the cutting edge materials with which valves are manufactured to the most advanced Minimally Invasive Surgery (MIS) tools and techniques, the professionals at Sorin Group’s Heart Valve Business Unit have achieved breakthroughs that have been copied or adopted by nearly every other valve manufacturer.
Never satisfied, we continue to deliver innovations that improve both the implantation and repair processes utilized by surgeons, as well as the quality of life for their patients. Our focus today is on enabling lesser invasive surgeries that achieve superior outcomes and return patients to their normal lives faster. Sorin Group’s Heart Valve Business Unit's substantial R&D investment has yielded new innovations in stentless and sutureless bioprosthetic valves, and we have expanded our product offering to surgeons through our worldwide distribution of the Cardio Vision line of minimally invasive surgical instruments.
Sorin Group is a financially strong company with a global presence. Our innovations are embraced by more than 5,000 hospitals in more than 80 countries throughout the world. Today, our heart valve business unit offers one of the most comprehensive and innovative mechanical and biological product offerings in the industry, delivering on the promise of excellent hemodynamic performance, implant flexibility and exceptional durability. With your continued support, Sorin Group is quickly becoming the choice of Cardiac Surgeons Worldwide.
We invite you to bookmark this website and visit it often to see our latest innovations and company news. As always, we appreciate your business and your partnership in delivering the best care for cardiac surgery patients worldwide.